| Deprescribing proton pump inhibitors: evidence-based clinical practice guideline B Farrell, K Pottie, W Thompson, T Boghossian, L Pizzola, FJ Rashid, ... Canadian Family Physician 63 (5), 354-364, 2017 | 496 | 2017 |
| Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline K Pottie, W Thompson, S Davies, J Grenier, CA Sadowski, V Welch, ... Canadian Family Physician 64 (5), 339-351, 2018 | 320 | 2018 |
| Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action E Reeve, W Thompson, B Farrell European journal of internal medicine 38, 3-11, 2017 | 306 | 2017 |
| Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP) J Kaczorowski, LW Chambers, L Dolovich, JM Paterson, T Karwalajtys, ... Bmj 342, 2011 | 244 | 2011 |
| Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline LM Bjerre, B Farrell, M Hogel, L Graham, G Lemay, L McCarthy, ... Canadian Family Physician 64 (1), 17-27, 2018 | 235 | 2018 |
| What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process B Farrell, C Tsang, L Raman-Wilms, H Irving, J Conklin, K Pottie PloS one 10 (4), e0122246, 2015 | 232 | 2015 |
| Integrating family medicine and pharmacy to advance primary care therapeutics L Dolovich, K Pottie, J Kaczorowski, B Farrell, Z Austin, C Rodriguez, ... Clinical Pharmacology & Therapeutics 83 (6), 913-917, 2008 | 206 | 2008 |
| Deprescribing: what is it and what does the evidence tell us? W Thompson, B Farrell The Canadian journal of hospital pharmacy 66 (3), 201, 2013 | 195 | 2013 |
| Deprescribing versus continuation of chronic proton pump inhibitor use in adults TA Boghossian, W Thompson, V Welch, P Moayyedi, C Rojas‐Fernandez, ... Cochrane Database of Systematic Reviews, 2017 | 194 | 2017 |
| Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline B Farrell, C Black, W Thompson, L McCarthy, C Rojas-Fernandez, ... Canadian Family Physician 63 (11), 832-843, 2017 | 183 | 2017 |
| Integrating pharmacists into family practice teams: physicians’ perspectives on collaborative care K Pottie, B Farrell, S Haydt, L Dolovich, C Sellors, N Kennie, W Hogg, ... Canadian Family Physician 54 (12), 1714-1717. e5, 2008 | 149 | 2008 |
| Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing B Farrell, K Pottie, CH Rojas-Fernandez, LM Bjerre, W Thompson, ... PLoS One 11 (8), e0161248, 2016 | 140 | 2016 |
| Guidelines for pharmacists integrating into primary care teams D Jorgenson, D Dalton, B Farrell, RT Tsuyuki, L Dolovich Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 146 (6), 342-352, 2013 | 116 | 2013 |
| Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT (†) project K Pottie, S Haydt, B Farrell, N Kennie, C Sellors, C Martin, L Dolovich Research in Social and Administrative Pharmacy 5 (4), 319-326, 2009 | 109 | 2009 |
| Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines B Farrell, L Richardson, L Raman-Wilms, D de Launay, MW Alsabbagh, ... Research in Social and Administrative Pharmacy 14 (1), 18-25, 2018 | 103 | 2018 |
| Atypical antipsychotics for insomnia: a systematic review W Thompson, TAW Quay, C Rojas-Fernandez, B Farrell, LM Bjerre Sleep Medicine 22, 13-17, 2016 | 101 | 2016 |
| Pharmacist provision of primary health care: a modified Delphi validation of pharmacists' competencies N Kennie-Kaulbach, B Farrell, N Ward, S Johnston, A Gubbels, T Eguale, ... BMC Family practice 13, 1-9, 2012 | 99 | 2012 |
| Working in interprofessional primary health care teams: what do pharmacists do? B Farrell, N Ward, N Dore, G Russell, R Geneau, S Evans Research in Social and Administrative Pharmacy 9 (3), 288-301, 2013 | 86 | 2013 |
| Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary E Reeve, B Farrell, W Thompson, N Herrmann, I Sketris, PJ Magin, ... Medical Journal of Australia 210 (4), 174-179, 2019 | 83 | 2019 |
| Polypharmacy: optimizing medication use in elderly patients D Kwan, B Farrell Practice 20, 25, 2013 | 83 | 2013 |
